✦ LIBER ✦

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer

✍ Scribed by Hendrik Andreas Wolff; Tobias Overbeck; Ralph M. Roedel; Robert M. Hermann; Markus K. A. Herrmann; Tereza Kertesz; Hilke Vorwerk; Andrea Hille; Christoph Matthias; Clemens F. Hess; Hans Christiansen

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 258 KB
Volume: 135
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-008-0532-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cisplatin for locally advanced

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

✍ Kathleen A. Havlin; John G. Kuhn; J. William Myers; Robert F. Ozols; Douglas E. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Hyperfractionated accelerated radiothera

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

Concomitant low-dose cisplatin and three

Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity

✍ Harold Lau; Sony Brar; Desiree Hao; Jack MacKinnon; Don Yee; Stefan Gluck 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

Background. Our center sought to implement a simple chemoradiotherapy schedule for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) with minimal toxicity to achieve rates of overall survival comparable to other schedules. Methods. The chemoradiotherapy schedule co

Radiochemotherapy Including Cisplatin Al

Radiochemotherapy Including Cisplatin Alone versus Cisplatin + 5-Fluorouracil for Locally Advanced Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck

✍ Silke Tribius; Stefanie Kronemann; Yasemin Kilic; Ursula Schroeder; Samer Hakim; 📂 Article 📅 2009 🏛 Springer 🌐 German ⚖ 307 KB

Prognostic value of primary tumor volume

Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma

✍ Frank J. P. Hoebers; Frank A. Pameijer; Josien de Bois; Wilma Heemsbergen; Alfon 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

## Abstract ## Background. The purpose of this study was to evaluate the prognostic value of tumor volume in head and neck squamous cell carcinoma treated with chemoradiation. ## Methods. Forty‐six patients were treated with radiotherapy and cisplatin (6 mg/m^2^ IV x20, daily). Baseline primary

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we